YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
The three benchmark Wall Street indexes delivered mixed performance for the week ended October 2, 2026. The Dow Jones Industrial Average fell 1.26%, while the S&P 500 declined 0.27%. The Nasdaq Composite, however, gained 0.45%. Stocks face…
Earlier this month, Thermo Fisher Scientific announced several product and collaboration updates, including the cGMP-ready Gibco CHO-K1 Catalog Panel for bioprocessing, a reseller agreement to distribute Evosep's Eno separation platform in…
Biodesix BDSX recently announced strategic progress in two molecular residual disease (MRD) programs to expand access to blood-based cancer monitoring. The company is developing tumor-informed and tumor-naive solutions that detect circulat…
Biodesix, Inc. Biodesix-led tumor-informed and tumor-naïve programs draw on the company's bioinformatics and diagnostics test development expertise LOUISVILLE, Colo., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a lead…
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer - Scott Hutton Chief Financial Officer - Robin Harper Cowie Full Conference Call Transcript Operator: Good day and thank…
Key Points Interested in Biodesix, Inc.? Here are five stocks we like better. Biodesix reaffirmed full-year revenue guidance of $108 million to $114 million, representing roughly 25% year-over-year growth at the midpoint, and maintained it…
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Agilon Health (AGL) been one of those stocks this year? A quick glance at the company's year-to-date…
A strong stock as of late has been Biodesix, Inc. (BDSX). Shares have been marching higher, with the stock up 16.1% over the past month. The stock hit a new 52-week high of $25.51 in the previous session. Biodesix has gained 265.6% since t…
(RTTNews) - The following biotech stocks reached a 52-week high on August 10, 2026, driven by key catalysts such as positive quarterly reports or the release of promising results from clinical trials. Silence Therapeutics plc (SLN) Silence…
Key Points Interested in Biodesix, Inc.? Here are five stocks we like better. Revenue increased 34% year over year to $26.9 million, driven by a 42% rise in diagnostic testing revenue and a 38% increase in tests processed. Primary-care tes…
Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.86. This compares to a loss of $1.6 per share a year ago. These figures are adjusted for non-recurring items. This…
Tenet Healthcare Corporation THC is well-poised to grow, backed by the expanding adjusted admissions. Its solid Ambulatory Care segment performance is also a major tailwind. In the year-to-date period, shares of Tenet Healthcare have gaine…
Elevance Health, Inc. ELV recently filed a lawsuit against the Centers for Medicare & Medicaid Services (CMS), arguing that the agency unfairly changed the Medicare Advantage Star Ratings of one of its competitors after the ratings had alr…
(RTTNews) - "To be a successful business owner and investor, you have to be emotionally neutral to winning and losing. Winning and losing are just part of the game," said Robert Kiyosaki, American entrepreneur, investor, and author of Rich…
Inspire Medical Systems INSP recently showcased new clinical data, technology advancements and cardiovascular outcomes research at SLEEP 2026, the annual meeting of the Associated Professional Sleep Societies. A major focus of the company'…
Synovis Micro Companies Alliance, Inc. (Synovis MCA), a subsidiary of Baxter International BAX, recently entered into a multi-year distribution agreement with MediThinQ. Under the agreement, Synovis MCA will commercialize SHIYA, MediThinQ'…
Biodesix, Inc. BDSX shares ended the last trading session 10.5% higher at $16.81. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 5.9% gain over…
AngioDynamics ANGO recently announced that the FDA has approved its IDE application to initiate the RELIEF study, which will evaluate the irreversible electroporation (IRE) technology delivered by the company's NanoKnife System. The IRE wi…
LivaNova LIVN recently announced new data from the PolySync substudy showing that its PolySync programming algorithm increased the cumulative apnea-hypopnea index (AHI) response rate from 65% to 84.5% in patients with moderate-to-severe Ob…
DexCom DXCM received FDA clearance for its Stelo Glucose Biosensor System for use in children aged two years and older who do not use insulin. The clearance expands access to the company's over-the-counter (OTC) continuous glucose monitori…
GE HealthCare Technologies Inc. GEHC recently expanded its clinical engineering services relationship with Carilion Clinic to support patient care and community health initiatives across Virginia. Under the collaboration, Carilion Clinic w…
Organon & Co. OGN recently announced that the FDA has approved a supplemental Biologics License Application (sBLA) for TOFIDENCE (tocilizumab-bavi), expanding the drug’s indications to include severe or life-threatening cytokine release sy…
Humana Inc. HUM recently agreed to sell all, or substantially all, of its remaining minority stake in Gentiva, the hospice and palliative care company that emerged from the restructuring of Kindred at Home's hospice and personal care opera…
Hinge Health Inc. HNGE recently announced the expansion of HingeSelect to include orthopedic surgery, enabling the platform to deliver coordinated care across the entire musculoskeletal (MSK) treatment journey. The HingeSelect platform now…
NeuroPace, Inc. NPCE is well-positioned for solid growth, driven by strong RNS adoption, expanding referral networks and AI-driven innovations that enhance efficiency and utilization. The potential IGE indication offers a long-term growth…
AMN Healthcare Services AMN recently announced the acquisition of Jaide Health, an AI-enabled medical interpretation and translation platform, to expand language access for patients with Limited English Proficiency across the healthcare jo…
Brookdale Senior Living Inc.’s BKD May 2026 occupancy update points to continued momentum. Weighted average occupancy reached 82.5%, up 250 basis points from the prior-year period and 20 basis points from April. The company typically gener…
For Immediate Release Chicago, IL – June 9, 2026 – Today, Zacks Equity Research discusses BrightSpring Health Services BTSG, Biodesix, Inc. BDSX and HealthEquity, Inc. HQY. Industry: Medical Services Link: https://www.zacks.com/commentary/…
Merit Medical Systems, Inc. MMSI is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid product performance and its continued spending on research and development, is expect…
Natera NTRA recently announced a collaboration with CytoDyn to evaluate circulating tumor DNA (ctDNA) dynamics and generate real-world molecular data in support of the latter’s metastatic colorectal cancer (mCRC) program. The collaboration…
The Medical Services sector is undergoing a rapid change as digital health expands, value-based care gains traction, and patient-centric and precision medicine solutions draw increasing attention. Demand for remote treatment continues to a…
Glaukos Corporation’s GKOS growth prospects are supported by the continued expansion of interventional glaucoma, growing clinical and commercial synergies between iDose TR and iStent infinite, and the potential for long-term operating leve…
AMN Healthcare Services, Inc. AMN is well-poised for growth in the coming quarters, courtesy of its broad array of services. The optimism is led by strong momentum in its Managed Services Program (MSP), rising labor disruption demand and i…
NeuroPace NPCE recently announced that the FDA has approved its ECoG Assistant, its first AI-driven feature to assist clinicians in epilepsy care. With this approval, the company takes a step forward in its AI platform strategy, applying i…
Natera NTRA recently announced a collaboration with Diakonos Oncology to incorporate its Signatera molecular residual disease test into Diakonos’ DOC-RM Phase I/II investigational immunotherapy trial for patients with refractory melanoma.…
CONMED Corporation CNMD is well-positioned for growth on the back of rising adoption of its high-margin, differentiated platforms like AirSeal, Buffalo Filter and BioBrace. The company’s long-term prospects seem good as robotic procedure v…